Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lilac Therapeutics is a clinical-stage biotech company focused on preventing recurrent kidney stones. Kidney stones affect 1 in 11 people in the U.S. and lead to 1.5 million emergency visits each year, often resulting in severe pain, hospitalization, and long-term complications including infections and kidney failure. Most patients who experience one stone are at high risk for recurrence?and currently, there are no approved th...
Lilac Therapeutics is a clinical-stage biotech company focused on preventing recurrent kidney stones. Kidney stones affect 1 in 11 people in the U.S. and lead to 1.5 million emergency visits each year, often resulting in severe pain, hospitalization, and long-term complications including infections and kidney failure. Most patients who experience one stone are at high risk for recurrence?and currently, there are no approved therapies to prevent future stones. Lilac is working to change that.

List your booth number for exhibitions, ask us